NOVARTIS AG CHF0.49 (REGD)NOVARTIS AG CHF0.49 (REGD)NOVARTIS AG CHF0.49 (REGD)

NOVARTIS AG CHF0.49 (REGD)

No trades
See on Supercharts

Price target

100.270.00 0.00%
The 19 analysts offering 1 year price forecasts for 0QLR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 26 analysts giving stock ratings to 0QLR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

0QLR EPS for the last quarter is 1.62 CHF despite the estimation of 1.51 CHF. In the next quarter EPS is expected to reach 1.67 CHF. Track more of NOVARTIS AG CHF0.49 (REGD) financials and stay on top of what is up with the company.
In the next quarter NOVARTIS AG CHF0.49 (REGD) revenue is expected to reach ‪11.18 B‬ CHF. Check out NOVARTIS AG CHF0.49 (REGD) revenue and earnings and make informed decisions.
According to analysts, 0QLR price target is 100.27 CHF with a max estimate of 119.58 CHF and a min estimate of 74.33 CHF. Check if this forecast comes true in a year, meanwhile keep track of the current situation with 0QLR news and stock market news.
We've gathered opinions of 26 analysts rating 0QLR stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.